OxervateUSPackag_1534470705843-3-HR The safety and efficacy of Oxervate was evaluated in 2 independent, double-masked, randomized, multicenter, controlled clinical trials involving patients with ...
It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%.” - The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, January ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback